Fundz

Surface Pharmaceuticals, Inc. reported raising $15 Million in an initial SEC Form D filing, from an offering of $20 Million

PRIVATEMay 22, 2018$15M of $20M raised

Amount Raised

$15 Million

$15 Million sold, per SEC Form D (first sale May 22, 2018)

Round Type

Venture

PleasantonBiotechnologyHealthcareHealth CareBiopharma

Quick answer

Surface Ophthalmics, Inc. raised $15 Million in a funding round, dated May 22, 2018. Surface Ophthalmics, Inc. is based in Pleasanton, California, United States.

How much did Surface Ophthalmics, Inc. raise?
Surface Ophthalmics, Inc. raised $15 Million in a funding round on May 22, 2018.
What does Surface Ophthalmics, Inc. do?
Surface Ophthalmics is a pioneering biopharmaceutical firm dedicated to the discovery and market introduction of novel treatments for diseases affecting the ocular surface.
Where is Surface Ophthalmics, Inc. based and how big is it?
Surface Ophthalmics, Inc. is based in Pleasanton, California, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Biopharma around the same time

Companies in the same sectors as Surface Ophthalmics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Citius Pharmaceuticals, Inc. raised $84K (Seed) on May 22, 2018.
  • Aquestive Therapeutics, Inc. raised $9.1M on May 9, 2018.
  • Urotronic, Inc. raised $6.1M on July 5, 2018.
  • Amwell raised $291M on June 29, 2018.
  • Amwell raised $767K (Seed) on June 29, 2018.
  • Revalesio raised $6M on June 27, 2018.

Who to call at Surface Ophthalmics, Inc., and when

A new round usually means Surface Ophthalmics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Surface Ophthalmics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Surface Ophthalmics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Surface Ophthalmics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Surface Ophthalmics, Inc.

Location

5000 HOPYARD ROAD

Pleasanton, California, United States

About

Surface Ophthalmics is a pioneering biopharmaceutical firm dedicated to the discovery and market introduction of novel treatments for diseases affecting the ocular surface. Our mission is to address critical unmet needs in eye care by harnessing in-depth expertise, a dynamic strategy, operational efficiency, and distinctive clinical advantages.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Surface Ophthalmics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Surface Ophthalmics, Inc.'s next move

See what Strategic adds

Surface Ophthalmics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.